GlassScriptPhysician profile
Debra K Lebo
NPI 1760552152
$1,854.10
in general payments reported to CMS, 2019-2025
20 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $120 · 2021: $330 · 2022: $54.24 · 2023: $330 · 2024: $421 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.02 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $340.35 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima, Acessa Provu System |
| Aspira Women'S Health INC | $243.74 | 2020-2024 | Ova1 |
| Abbvie INC. | $215.75 | 2019-2023 | |
| Becton, Dickinson and Company | $200.00 | 2024 | Arista Ah Flexitip |
| Organon LLC | $139.75 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.41 | 2019-2025 | |
| Intuitive Surgical, INC. | $105.24 | 2019 | |
| Baxter Healthcare | $63.82 | 2023 | Tisseel |
| Coopersurgical, INC. | $61.10 | 2021-2025 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $52.93 | 2019-2020 | |
| Ethicon US, LLC | $48.68 | 2019-2023 | Echelon Flex, Ethicon |
| Duchesnay USA Incorporated | $46.33 | 2019 | |
| Pfizer INC. | $36.68 | 2021-2023 | |
| Amag Pharmaceuticals, INC. | $34.92 | 2019 | |
| Therapeuticsmd, INC. | $33.34 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $27.38 | 2024 | Injectafer |
| Astellas Pharma US INC | $25.70 | 2023 | Veozah |
| Virtus Pharmaceuticals LLC | $17.66 | 2021 | |
| Abbott Laboratories | $16.88 | 2024 | Freestyle Libre 3 |
| Myovant Sciences INC. | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Lebo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.